# Autoantibodies Against Type I Interferon in Patients Affected With Ph-negative Myeloproliferative Neoplasms (MPN-IFN Study)

> **NCT07204366** · — · ACTIVE_NOT_RECRUITING · sponsor: **Fondazione IRCCS Policlinico San Matteo di Pavia** · enrollment: 219 (actual)

## Conditions studied

- Myeloproliferative Disease
- COVID - 19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07204366
- **Lead sponsor:** Fondazione IRCCS Policlinico San Matteo di Pavia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-05-06
- **Primary completion:** 2030-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 219 (ACTUAL)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07204366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07204366, "Autoantibodies Against Type I Interferon in Patients Affected With Ph-negative Myeloproliferative Neoplasms (MPN-IFN Study)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07204366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*